Corus Pharma coruspharma.com


Public lists: Pharma Startups (4743)

Corus Pharma, Inc. was acquired by Gilead Sciences in August 2006. Prior to the acquisition, Corus was developing small molecule drugs for the treatment of respiratory diseases.

Corus Pharma, Inc. was acquired by Gilead Sciences in August 2006. Prior to the acquisition, Corus was developing small molecule drugs for the treatment of respiratory diseases.

Company (Acquired)

Phone: 206-728-5090

Fax:

2025 1st Avenue
Suite 800
Seattle, 98121
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Corus Pharma $123.5M Jul 19, 2006
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Corus Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 21 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Oxagen

Abingdon, United Kingdom
Alive / ActiveOxagen is a biopharmaceutical company that develops small molecule drugs for inflammatory and respiratory diseases.Login to see details

Panacos Pharmaceuticals

Watertown, Massachusetts, United States
Alive / ActivePanacos is developing anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Per the company, Panacos' proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus fusion.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)